Citation: | ZHANG Li, KANG Mei, CHEN Zhongju, CAO Cunwei, MA Ling, ZHU Min, JIN Yan, XIA Yun, CHU Yunzhuo, LIU Wenen, GUO Dawen, HUANG Ying, DUAN Jinju, WANG Junrui, XU Xuesong, MA Xiaoling, LI Bin, LIAO Kang, ZHU Pengfei, WANG Yao, XU Yingchun, MING Liang. Epidemiology of Clinical Mold Infections in China: A Multicenter Retrospective Study[J]. Medical Journal of Peking Union Medical College Hospital, 2023, 14(3): 559-565. DOI: 10.12290/xhyxzz.2022-0654 |
[1] |
Bongomin F, Gago S, Oladele RO, et al. Global and Multi-National Prevalence of Fungal Diseases: Estimate Precision[J]. J Fungi (Basel), 2017, 3: 57. DOI: 10.3390/jof3040057
|
[2] |
WHO fungal priority pathogens list to guide research, development and public health action[M]. World Health Organization, 2022.
|
[3] |
von Lilienfeld-Toal M, Wagener J, Einsele H, et al. Inva-sive Fungal Infection[J]. Dtsch Arztebl Int, 2019, 116: 271-278.
|
[4] |
Wang H, Wang Y, Yang QW, et al. A national survey on fungal infection diagnostic capacity in the clinical mycology laboratories of tertiary care hospitals in China[J]. J Microbiol Immunol Infect, 2020, 53: 845-853. DOI: 10.1016/j.jmii.2020.03.016
|
[5] |
Xiao M, Chen SC, Kong F, et al. China Hospital Invasive Fungal Surveillance Net (CHIF-NET) Study Group. Five-year China Hospital Invasive Fungal Surveillance Net (CHIF-NET) study of invasive fungal infections caused by noncandidal yeasts: species distribution and azole susceptibility[J]. Infect Drug Resist, 2018, 11: 1659-1667.
|
[6] |
Wang Q, Cai X, Li Y, et al. Molecular identification, antifungal susceptibility, and resistance mechanisms of patho-genic yeasts from the China antifungal resistance surveillance trial (CARST-fungi) study[J]. Front Microbiol, 2022, 13: 1006375. DOI: 10.3389/fmicb.2022.1006375
|
[7] |
Firacative C. Invasive fungal disease in humans: are we aware of the real impact?[J]. Mem Inst Oswaldo Cruz, 2020, 115: e200430. DOI: 10.1590/0074-02760200430
|
[8] |
Rotjanapan P, Chen YC, Chakrabarti A, et al. Epidemio-logy and clinical characteristics of invasive mould infections: A multicenter, retrospective analysis in five Asian countries[J]. Medical Mycol, 2018, 56: 186-196. DOI: 10.1093/mmy/myx029
|
[9] |
Wei L, Zhu P, Chen X, et al. Mucormycosis in Mainland China: A Systematic Review of Case Reports[J]. Mycopathologia, 2022, 187: 1-14. DOI: 10.1007/s11046-021-00607-4
|
[10] |
Vallabhaneni S, Benedict K, Derado G, et al. Trends in Hospitalizations Related to Invasive Aspergillosis and Mucormycosis in the United States, 2000—2013[J]. Open Forum Infect Dis, 2017, 4: ofw268. DOI: 10.1093/ofid/ofw268
|
[11] |
Krishna V, Bansal N, Morjaria J, et al. COVID-19-Associated Pulmonary Mucormycosis[J]. J Fungi, 2022, 8: 711. DOI: 10.3390/jof8070711
|
[12] |
Song Y, Liu X, Yang Z, et al. Molecular and MALDI-ToF MS differentiation and antifungal susceptibility of prevalent clinical Fusarium species in China[J]. Mycoses, 2021, 64: 1261-1271. DOI: 10.1111/myc.13345
|
[13] |
孙声桃, 吕奇学, 韩雷, 等. 我国中原地区653株真菌性角膜炎分离镰刀菌的基因型及药物敏感性[J]. 中华眼科杂志, 2015, 51: 660-667. DOI: 10.3760/cma.j.issn.0412-4081.2015.09.005
|
[14] |
杨之辉, 余进, 李若瑜. 中国大陆地区赛多孢霉感染流行现状的回顾性分析[J]. 中国真菌学杂志, 2019, 14: 183-188, 192. DOI: 10.3969/j.issn.1673-3827.2019.03.014
|
[15] |
Chen M, Zhu X, Cong Y, et al. Genotypic diversity and antifungal susceptibility of Scedosporium species from clinical settings in China[J]. Mycoses, 2022, 65: 1159-1169. DOI: 10.1111/myc.13507
|
[16] |
Paulussen C, Hallsworth JE, álvarez-Pérez S, et al. Ecology of aspergillosis: insights into the pathogenic potency of Aspergillus fumigatus and some other Aspergillus species[J]. Microb Biotechnol, 2017, 10: 296-322. DOI: 10.1111/1751-7915.12367
|
[17] |
Jeong W, Keighley C, Wolfe R, et al. The epidemiology and clinical manifestations of mucormycosis: a systematic review and meta-analysis of case reports[J]. Clin Microbiol Infec, 2019, 25: 26-34. DOI: 10.1016/j.cmi.2018.07.011
|
[18] |
Jing R, Yang WH, Xiao M, et al. Species identification and antifungal susceptibility testing of Aspergillus strains isolated from patients with otomycosis in northern China[J]. J Microbiol Immunol Infect, 2022, 55: 282-290. DOI: 10.1016/j.jmii.2021.03.011
|
[19] |
Gharaghani M, Seifi Z, Zarei Mahmoudabadi A. Otomycosis in Iran: A Review[J]. Mycopathologia, 2015, 179: 415-424. DOI: 10.1007/s11046-015-9864-7
|
[20] |
Lin Y, Zhang J, Han X, et al. A retrospective study of the spectrum of fungal keratitis in southeastern China[J]. Ann Palliat Med, 2021, 10: 9480-9487. DOI: 10.21037/apm-21-1949
|